EUCTR2014-000586-45-BE进行中（未招募）1 期
Oxytocin-based pharmacotherapy for Autism Spectrum Disorders:Investigating the neural and behavioral effects of a promising interventionapproach - Oxytocin study
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- KU Leuven
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Young male adult participants with autism spectrum disorder will be
- •recruited mainly from the Expertise Centrum Autisme (ECA) of the UZ
- •Leuven, Belgium.
- •Participants are selected when diagnosed with ASD by a
- •multidisciplinary team of experienced clinicians as defined by the DSMIV-
- •TR (or DSM-V) criteria (Diagnostic and Statistical Manual of Mental
- •Disorders). In addition to the DSM-criteria, the Developmental
- •Dimensional Diagnostic instrument (3DI, David Skuse) and the Autism
- •Diagnostic Observation Schedule (ADOS) will be adopted as diagnostic
- •Participants within an age-range of 18-30 will be included.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 80
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Participants will be excluded based on the following criteria:
- •(i) associated psychiatric or neurological disorders (e.g. ADHD),
- •(ii) use of psychotropic medication,
- •(iii) any contraindication to neuroimaging research as assessed with the
- •MRI screening list (see below)
- •MRI contraindications
- •pacemaker, implanted defibrillator, ear implant / a cochlear implant,
- •insulin or implanted pump, a neurostimulator or VP shunt, any metallic
- •object in the eyes (metallic fragments)
研究者
相似试验
已完成
不适用
Intranasal Oxytocin for Autism Spectrum Disorder and Comorbid Severe Intellectual Disabilities:open-label studyAutism spectrum disorder severe intellectual disabilitiesJPRN-UMIN000024339ational Hospital Organization Hizen Psychiatric Center7
已完成
不适用
Intranasal Oxytocin for Autism Spectrum Disorder and Comorbid Severe Intellectual Disabilities:Open-label long term studyAutism Spectrum Disorder Severe intellectual disabilitiesJPRN-UMIN000028650ational Hospital Organization Hizen Psychiatric Center3
已完成
4 期
Neural and Behavioral Effects of Oxytocin in Autism Spectrum DisordersAutism Spectrum DisordersNCT02940574KU Leuven40
已完成
不适用
Intranasal Oxytocin for the Treatment of Autism Spectrum DisordersAutism Spectrum DisordersNCT01337687Montefiore Medical Center19
已完成
2 期
Single Dose Intranasal Oxytocin and Cognitive Effects in AutismAutism Spectrum DisordersNCT02493426University of Minnesota27